# Editas Medicine (EDIT) — News

EDIT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/edit/news

## Recent headlines

- [H&M: No indications data environment has been compromised](https://www.ainvest.com/news/indications-data-environment-compromised-2610) — AInvest Wire, Oct 12, 2026
  On June 4, 2025, H&M experienced a significant system failure that disrupted payment processing across its UK stores, leaving customers unable to complete purchases for several hours. The issue, which affected multiple locations including a London branch, was attributed to problems with the…
- [Editas Medicine - To begin patient dosing in 2026, report initial data in Q1 2027](https://www.ainvest.com/news/editas-medicine-patient-dosing-2026-report-initial-data-q1-2027-2610) — AInvest Wire, Oct 8, 2026
  Editas Medicine Inc. (NASDAQ:EDIT) is preparing to initiate patient dosing for one of its key programs in 2026, with initial clinical data expected in the first quarter of 2027. This development marks a significant milestone for the company as it advances its pipeline in the field of genetic…
- [Editas Medicine - Receives approval to initiate phase 1/2 trial of edit-401 in Australia](https://www.ainvest.com/news/editas-medicine-receives-approval-initiate-phase-1-2-trial-edit-401-australia-2610) — AInvest Wire, Oct 8, 2026
- [Editas Medicine - Expects topline safety and efficacy data for edit-401 later in 2027](https://www.ainvest.com/news/editas-medicine-expects-topline-safety-efficacy-data-edit-401-2027-2610) — AInvest Wire, Oct 8, 2026
- [Editas Medicine receives approval to initiate first-in-human clinical trial of edit-401 in patients with hyperlipidemia](https://www.ainvest.com/news/editas-medicine-receives-approval-initiate-human-clinical-trial-edit-401-patients-hyperlipidemia-2610) — AInvest Wire, Oct 8, 2026

## Similar Stocks

- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [NTLA](https://www.lighthorse.io/tickers/ntla) — Intellia Therapeutics, Inc. - Common Stock
- [BEAM](https://www.lighthorse.io/tickers/beam) — Beam Therapeutics Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).